Voloridge Investment Management
ANGO icon

Voloridge Investment Management’s AngioDynamics ANGO Stock Holding History

Voloridge Investment Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-27,799
Closed -$383K – 1348
2022
Q4 		$383K Buy
+27,799
New +$387K ﹤0.01% 1312

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voloridge Investment Management's ANGO Position: Q1 2023 in Review

Voloridge Investment Management sold out of AngioDynamics (ANGO) in Q1 2023, closing a stake of 27,799 shares — an estimated $383K sold.

Voloridge Investment Management first reported a position in ANGO in Q4 2022 and held it in 1 quarter. The position peaked at $383K in Q4 2022. 153 funds tracked by Wall St. Rank hold ANGO as of Q1 2023.

  • Voloridge Investment Management reported no remaining AngioDynamics position as of Q1 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 27,799 AngioDynamics shares in Q1 2023, an estimated $383K.
  • Voloridge Investment Management first reported a position in AngioDynamics in Q4 2022 and held it in 1 quarter.
  • Voloridge Investment Management's AngioDynamics position peaked at $383K in Q4 2022.
  • 153 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2023.

Based on Voloridge Investment Management's 13F filing for Q1 2023, filed 15 May 2023.